US Patent Issued to APR Applied Pharma Research on April 21 for "Therapeutic uses of oxidizing hypotonic acid solutions" (Swiss, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,402, issued on April 21, was assigned to APR Applied Pharma Research SA (Geneva).

"Therapeutic uses of oxidizing hypotonic acid solutions" was invented by Giorgio Reiner (Como, Italy), Paolo Galfetti (Balerna, Switzerland) and Roberto De Noni (Balerna, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating or preventing ulcers caused by Epidermolysis Bullosa ("EB"), EGFR inhibitor-induced skin toxicities, lesions caused by Hailey-Hailey Disease ("HHD"), Buruli Ulcers, and SARS-CoV-2 infections, by topically applying a hypotonic, acid oxidizing solution containing hypochlorous acid (HClO) to the affected area."

The patent w...